NASDAQ · Biotechnology

CRSP (CRSP) Stock

$46.73 +0.41% NASDAQ: CRSP Healthcare

Valuation

MetricValue
Price$46.73
Market Cap$4.51B
P/E Ratio-12.98
P/B Ratio2.81
P/S Ratio1241.87
EPS (TTM)$0.00
52-Week High$78.48
52-Week Low$34.87
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-31.21%
ROA-14.06%
ROCE-34.58%
Gross Margin-14200.00%
Operating Margin-89.33%
Net Margin-138.57%
Debt/Equity0.43
Current Ratio17.97

Annual Financials (USD)

Metric20212022202320242025
Revenue$913.0M$0$370.0M$35.0M$4.0M
Operating Profit$374.0M$-673.0M$-223.0M$-467.0M$-568.0M
Net Profit$378.0M$-650.0M$-154.0M$-366.0M$-582.0M
EPS$4.70$-8.36$-1.94$-4.34$-6.47
Op Margin40.9%-154394.7%-60.1%-1333.0%-16191.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.8B$2.2B$2.2B$2.2B$2.3B
Total Liabilities$352.0M$368.0M$347.0M$310.0M$343.0M
Cash$923.0M$212.0M$389.0M$298.0M$355.0M
Borrowings$225.0M$244.0M$239.0M$224.0M$395.0M

Latest News

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It Zacks · Jul 14, 2026 CRISPR Therapeutics AG (CRSP) Stock Dips While Market Gains: Key Facts Zacks · Jul 10, 2026 3 Reasons to Buy CRISPR Therapeutics Stock Motley Fool · Jul 10, 2026 NTLA Surges 38% in a Month: Should You Buy, Sell or Hold the Stock? Zacks · Jul 9, 2026 Vertex’s Crinetics Deal Balances Growth with Integration Risk MarketBeat · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$539.0M$-496.0M$-260.0M$-143.0M$-345.0M
Investing Cash Flow$-1.1B$-296.0M$365.0M$-282.0M$-33.0M
Financing Cash Flow$38.0M$38.0M$0$31.0M$0
Net Cash Flow$-246.0M$-716.0M$178.0M$-91.0M$49.0M
Free Cash Flow$457.0M$-533.0M$-270.0M$-145.0M$-346.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.23
EV / EBITDA-6.48
FCF Yield-7.87%
Quick Ratio17.96
Interest Coverage—
Return 1Y-28.11%
Return 3Y-16.46%
Return 5Y-61.24%

Ownership

Insiders Held5.91%
Institutions Held79.34%
Institutions Float Held84.33%
Institutional HolderSharesReport Date
ARK Investment Management, LLC11,313,6232026-03-31
Blackrock Inc.7,680,0732026-03-31
Orbis Allan Gray Ltd6,106,0112026-03-31
Capital World Investors4,725,0372026-03-31
State Street Corporation3,982,5002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACLXArcellx, Inc. $115.07 +0.02% -28.27 $6.73B 0.00%
AKROAkero Therapeutics, Inc. $54.65 +0.00% -19.87 $4.50B 0.00%
ARWR $86.01 +1.61% -7397.00 $12.12B 0.00%
CYTKCytokinetics, Incorporated $80.62 -0.15% -11.82 $10.03B 0.00%
KRYS $312.57 -8.37% 42.90 $9.21B 0.00%

About CRSP

CRSP stock trades at $46.73 with a market capitalization of $4.51B. The stock is valued at a price-to-earnings (P/E) ratio of -12.98, price-to-book of 2.81, price-to-sales of 1241.87. Over the past 52 weeks the stock has ranged between $34.87 and $78.48, and currently trades 40.5% below its 52-week high.

On profitability, CRSP generates a return on equity (ROE) of -31.21%, return on capital employed of -34.58%, an operating margin of -89.33%, a net profit margin of -138.57%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides